XML 27 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Share Based Compensation
6 Months Ended
Jun. 30, 2021
Share Based Compensation [Abstract]  
Share Based Compensation
8.
Share Based Compensation

We maintain share based payment plans that include a non-employee director stock purchase plan and a long-term incentive plan that permits the issuance of share based compensation, including stock options and non-vested share awards. The long-term incentive plan, which is shareholder approved, permits the grant of additional share based awards for up to 0.6 million shares of common stock as of June 30, 2021.  The non-employee director stock purchase plan permits the issuance of additional share based payments for up to 0.1 million shares of common stock as of June 30, 2021. Share based awards and payments are measured at fair value at the date of grant and are expensed over the requisite service period. Common shares issued upon exercise of stock options come from currently authorized but unissued shares.

A summary of restricted stock and performance stock units (“PSU”) granted pursuant to our long-term incentive plan follows:

 
 
Three Months Ended
June 30,
   
Six Months Ended
June 30,
 
 
 
2021
   
2020
   
2021
   
2020
 
 
     
Restricted stock
   
10,000
     
-
     
85,584
     
52,996
 
PSU
   
-
     
-
     
23,981
     
20,897
 

The shares of restricted stock and PSUs shown in the above table cliff vest after a period of three years.  The performance feature of the PSUs is based on a comparison of our total shareholder return over the three year period starting on the grant date to the total shareholder return over that period for an index of our banking peers.

Our directors may elect to receive all or a portion of their cash retainer fees in the form of common stock (either on a current basis or on a deferred basis) pursuant to the non-employee director stock purchase plan referenced above. Shares equal in value to that portion of each director’s fees that he or she has elected to receive in stock on a current basis are issued each quarter and vest immediately. Shares issued on a deferred basis are credited at the rate of 90% of the current fair value of our common stock and vest immediately.  During the six month periods ended June 30, 2021 and 2020 we issued 0.009 million and 0.011 million shares, respectively and expensed their value during those same periods.

Total compensation expense recognized for grants pursuant to our long-term incentive plan was $0.5 million and $0.8 million during the three and six month periods ended June 30, 2021, respectively, and was $0.4 million and $0.8 million during the same periods in 2020, respectively.  The corresponding tax benefit relating to this expense was $0.1 million and $0.2 million for the three and six month periods ended June 30, 2021, respectively and $0.1 million and $0.2 million for the same periods in 2020. Total expense recognized for non-employee director share based payments was $0.09 million and $0.19 million during the three and six month periods ended June 30, 2021, respectively, and was $0.09 million and $0.17 million during the same periods in 2020, respectively.  The corresponding tax benefit relating to this expense was $0.02 million and $0.04 million for the three and six month periods ended June 30, 2021, respectively and $0.02 million and $0.04 million during the same periods in 2020.

At June 30, 2021, the total expected compensation cost related to non-vested restricted stock and PSUs not yet recognized was $2.9 million.  The weighted-average period over which this amount will be recognized is 2.2 years.

A summary of outstanding stock option grants and related transactions follows:

 
Number of
Shares
   
Average
Exercise
Price
   
Weighted-
Average
Remaining
Contractual
Term (Years)
   
Aggregated
Intrinsic
Value
 
                     
(In thousands)
 
Outstanding at January 1, 2021
   
121,189
   
$
4.81
             
Granted
   
-
                     
Exercised
   
(37,450
)
   
2.76
             
Forfeited
   
-
                     
Expired
   
-
                     
Outstanding at June 30, 2021
   
83,739
   
$
5.72
     
2.1
   
$
1,339
 
                                 
Vested and expected to vest at June 30, 2021
   
83,739
   
$
5.72
     
2.1
   
$
1,339
 
Exercisable at June 30, 2021
   
83,739
   
$
5.72
     
2.1
   
$
1,339
 
A summary of outstanding non-vested restricted stock and PSUs and related transactions follows:

 
Number
of Shares
   
Weighted-
Average
Grant Date
Fair Value
 
Outstanding at January 1, 2021
   
207,117
   
$
22.70
 
Granted
   
109,565
     
20.45
 
Vested
   
(63,982
)
   
23.60
 
Forfeited
   
(10,754
)
   
22.63
 
Outstanding at June 30, 2021
   
241,946
   
$
21.45
 

Certain information regarding options exercised during the periods follows:

 
 
Three Months Ended
June 30,
   
Six Months Ended
June 30,
 
 
 
2021
   
2020
   
2021
   
2020
 
   
(In thousands)
   
(In thousands)
 
Intrinsic value
 
$
388
   
$
3
   
$
701
   
$
213
 
Cash proceeds received
 
$
44
   
$
1
   
$
104
   
$
42
 
Tax benefit realized
 
$
81
   
$
1
   
$
147
   
$
45